Biological and Environmental Research Ontology

Last uploaded: December 23, 2022

Id	http://purl.obolibrary.org/obo/NCIT_C78126 http://purl.obolibrary.org/obo/NCIT_C78126
Preferred Name	Dapagliflozin
Definitions	A selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Dapagliflozin selectively and potently inhibits SGLT2 compared to SGLT1, which is the cotransporter of glucose in the gut.
Type	http://www.w3.org/2002/07/owl#Class

definition	A selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Dapagliflozin selectively and potently inhibits SGLT2 compared to SGLT1, which is the cotransporter of glucose in the gut.
label	Dapagliflozin
prefLabel	Dapagliflozin
Legacy Concept Name	Dapagliflozin
in_subset	http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C173383 http://purl.obolibrary.org/obo/NCIT_C173381 http://purl.obolibrary.org/obo/NCIT_C176424 http://purl.obolibrary.org/obo/NCIT_C116977 http://purl.obolibrary.org/obo/NCIT_C116978 See more See less
Preferred_Name	Dapagliflozin
Chemical_Formula	C21H25ClO6
Display_Name	Dapagliflozin
PDQ_Open_Trial_Search_ID	802820
UMLS_CUI	C2353951
FDA_UNII_Code	1ULL0QJ8UC
prefixIRI	NCIT:C78126
NCI_Drug_Dictionary_ID	802820
Contributing_Source	CTRP FDA
subClassOf	http://purl.obolibrary.org/obo/NCIT_C98083
code	C78126
type	http://www.w3.org/2002/07/owl#Class
PDQ_Closed_Trial_Search_ID	802820
Semantic_Type	Pharmacologic Substance
CAS_Registry	461432-26-8

Delete	Subject	Author	Type	Created
No notes to display